Clinical Trials Logo

Filter by:
NCT ID: NCT03080467 Completed - Child Clinical Trials

Long-Term Outcome of Pediatric Traumatic Wound Repair: Suture Versus Tissue Adhesive

Start date: June 13, 2017
Phase:
Study type: Observational

This project is an observational trial investigating wound cosmetic appearance after repair of traumatic skin lacerations in the head area of pediatric patients with two different approaches to skin closure: sutures versus tissue adhesive. Photographs will be taken at two follow-up visits after repair and later assessed by external blinded plastic surgeon using standard cosmetic assessment scales. The investigators hypothesize that cosmetic wound outcome will be equivalent in these two wound repair treatment options.

NCT ID: NCT03079908 Withdrawn - Clinical trials for Robotic Surgery Training

Comparison of da Vinci Simulator vs LapSim Simulator

Start date: August 15, 2017
Phase: N/A
Study type: Interventional

Virtual reality surgical simulators (VRSS) are gaining popularity for general surgery training, both for conventional laparoscopic and robotically-assisted surgery. Although numerous studies have analysed the impact of VRSS training on surgical skills, there is a lack of data regarding the comparison of robotic VRSS (RVRSS) and laparoscopic VRSS (LVRSS) training on conventional laparoscopic skills among subjects with no prior surgical experience. The hypothesis of the present study is that RVRSS could improve conventional laparoscopic skills as much as laparoscopic LVRSS among naïve subjects

NCT ID: NCT03079583 Completed - Zinc Deficiency Clinical Trials

The Efficacy of Zinc-biofortified Rice in Bangladeshi Children

ZARI
Start date: April 1, 2018
Phase: N/A
Study type: Interventional

To assess the efficacy of the zinc biofortified rice on plasma zinc concentrations in infants from a rural area of Bangladesh.

NCT ID: NCT03079336 Completed - Clinical trials for Generalized Anxiety Disorder

Implementation of Psychological Treatment in Generalized Anxiety

IMPLEMENT2_0
Start date: January 2017
Phase: N/A
Study type: Interventional

Pragmatic randomized controlled trial (expected N = 80) of cognitive-behavioral therapy (CBT) to contrast two psychotherapeutic implementation strategies (State-of-the-Art welcome phase vs. prolonged focus on sudden changes). Blinded allocation of implementation strategy for patients; open label for therapists (no blinding possible), randomized allocation for patients, therapist allocation via ABAB-design (crossed-therapist design). Post treatment self-reported outcome will be measured based on a latent outcome factor (i. e. "outcome composite").

NCT ID: NCT03079206 Completed - Food Allergy Clinical Trials

Basophile Activation Testing (BAT) in Hazelnut Allergy (Hazelnut BAT Study)

Start date: February 22, 2017
Phase: N/A
Study type: Interventional

The proposed study intends to compare the outcome of food challenge in hazelnut allergic patients with the outcome of basophile activation tests using hazelnut extract and components.

NCT ID: NCT03078907 Completed - Clinical trials for Pulmonary Arterial Hypertension

Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension.

TRACE
Start date: November 8, 2017
Phase: Phase 4
Study type: Interventional

The primary objective of this study is to evaluate the effect of selexipag on the physical activity of patients with pulmonary arterial hypertension (PAH) in their daily life, by using a wearable wrist device (actigraph). The actigraph will collect data on daily life physical activity in the patient's real environment. In addition, the PAH symptoms and their impacts will be assessed by using an electronic patient reported outcome measure in the patient's real environment. Patients will be assigned randomly to either selexipag or placebo.

NCT ID: NCT03076307 Completed - Parkinson Disease Clinical Trials

DAT SPECT and Procedural Motor Skills in Parkinson's Disease

Start date: October 18, 2016
Phase: N/A
Study type: Interventional

Patients with Parkinson's disease (PD) are known to be affected by subtle cognitive impairment early in the disease course, mostly in the executive field. Procedural motor skills, mainly controlled by the basal ganglia associative loop (in particular dorsal caudate nucleus) (Rodriguez-Oroz et al., 2009), have also been studied in patients with PD (Schnider et al., 1995; Muslimovic et al., 2007; Terpening et al., 2013). However, the correlation of dopaminergic 123I-FP-CIT SPECT imaging and cognitive impairment has not been assessed. One reason is the absence of reference values for striatal uptake until recently. Last year, the investigators established local uptake reference values for DAT imaging based on a large cohort of subjects with non-degenerative conditions (Nicastro et al., 2016) and can therefore use these values to precisely assess uptake loss in patients with PD. With the present study, the investigators expect to enroll patients with early PD for whom a 123I-FP-CIT SPECT has been previously performed in the center. Subjects will perform a specific motor task based on mirror-drawing of star-shaped figures. This will be done by inverting the direction of horizontal/vertical computer mouse movements on the screen. Speed and error rates will be assessed for patients as well as healthy control subjects. Correlation with striatal SPECT uptake, especially caudate nucleus uptake, will be analyzed for PD patients. In addition, resting-state EEG will be performed for all subjects. General medication and dopaminergic drugs in particular, whenever used, will not be discontinued. For all subjects enrolled in the study, cognitive and neurological examination will be performed.

NCT ID: NCT03075670 Completed - Clinical trials for Congenital Bleeding Disorder

A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B

paradigmâ„¢7
Start date: March 7, 2017
Phase: Phase 1
Study type: Interventional

This trial is conducted in Europe and the United States of America. The aim of this trial is to compare the pharmacokinetics (the exposure of the trial drug in the body) of nonacog beta pegol (N9-GP) and ALPROLIX® in patients with haemophilia B.

NCT ID: NCT03075579 Recruiting - ADHD Clinical Trials

Atomoxetine, Diurnal Profiles of Cortisol and α-amylase

ADHDstress
Start date: December 1, 2016
Phase: N/A
Study type: Observational

Diurnal profiles of markers of the stress system are increasingly recognized as biomarkers of different kinds of depression and related states. They may also serve as markers of treatment success. However, this has not yet been studied in attention deficit disorder (ADHD). Especially, there is a paucity of research into the effect of ADHD medication on the diurnal profiles of cortisol as marker of the hypothalamic pituitary adrenal (HPA) system and of amylase as marker of the sympathetic adrenomedullar (SAM) system. The investigators propose a within subjects design with probands of a narrow age range (seven to ten years of age, same sex: boys only) in order to get first information about whether there is an effect of atomoxetine on these diurnal profiles of cortisol and amylase, what kind of effect it is and whether this effect is related to treatment success. The investigators control for motor activity by using actometer measurements.

NCT ID: NCT03075215 Completed - Heart Failure Clinical Trials

Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry

SMART Registry
Start date: April 14, 2017
Phase:
Study type: Observational [Patient Registry]

To learn in a general Cardiac Resynchronization Therapy Defibrillators (CRT-D) population, which optimization techniques are used and how effective they are. It will compare 12-month response rates among different optimization methods and characterize which selected subject subgroups achieve better response than others. A subset of SMART Registry subjects will contribute to the NG4 Post Market Clinical Follow Up (PMCF) Cohort whose objective is collecting data on the NG4 CRT-D features and device usage in a real world setting and monitor long term safety associated with these devices to support CE Mark.